![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
GL Kedderis and DE Rickert
The role of flavin-containing monooxygenase (FMO) in the decrease in cytochrome P-450 content during the microsomal metabolism of methimazole (N-methyl-2-mercaptoimidazole) was investigated by heat inactivation of FMO. Incubation of liver microsomes from untreated Fischer 344 rats with NADPH and methimazole resulted in a 25% loss of cytochrome P-450 detectable as its ferrous-carbon monoxide complex. The same extent of cytochrome P-450 loss was observed with 1 and 20 mM methimazole, suggesting saturation of the process. There was no significant loss of cytochrome P-450 when microsomal FMO was heat- inactivated prior to incubation with NADPH and methimazole. Heat pretreatment of the microsomes did not affect cytochrome P-450 concentrations and cytochrome P-420 was not observed. These results indicate that FMO-catalyzed metabolism of methimazole is necessary for the loss of cytochrome P-450 in microsomes from untreated rats. Sulfite and N-methylimidazole, the ultimate products of methimazole metabolism, did not cause a significant loss of cytochrome P-450. There was no loss of cytochrome P-450 when glutathione was included in the incubation with methimazole, suggesting that cytochrome P-450 loss was due to an interaction with oxygenated metabolites of methimazole formed by FMO. Losses of cytochrome P-450 were also observed after incubation of microsomes from phenobarbital- (31%) of beta-naphthoflavone-pretreated rats (44%) with NADPH and methimazole. In contrast to microsomes from untreated rats, heat inactivation of FMO did not prevent the loss of cytochrome P-450 in microsomes from the pretreated rats. These results indicate that both phenobarbital and beta-naphthoflavone induce isozymes of cytochrome P-450 capable of directly activating methimazole.
This article has been cited by other articles:
|
|
 |
|
  A. Kousba, R. Soll, S. Yee, and M. Martin Cyclic Conversion of the Novel Src Kinase Inhibitor [7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-Oxide Metabolite by Flavin-Containing Monoxygenases and Cytochrome P450 Reductase Drug Metab. Dispos., December 1, 2007; 35(12): 2242 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ortega, J. M Vila, M. D. Mauricio, G. Segarra, P. Medina, J. B Martinez-Leon, and S. Lluch Nitric oxide mediates abnormal responsiveness of thyroid arteries in methimazole-treated patients Eur. J. Endocrinol., April 1, 2005; 152(4): 551 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Virkel, A. Lifschitz, J. Sallovitz, A. Pis, and C. Lanusse COMPARATIVE HEPATIC AND EXTRAHEPATIC ENANTIOSELECTIVE SULFOXIDATION OF ALBENDAZOLE AND FENBENDAZOLE IN SHEEP AND CATTLE Drug Metab. Dispos., May 1, 2004; 32(5): 536 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Cashman and J. Zhang Interindividual Differences of Human Flavin-Containing Monooxygenase 3: Genetic Polymorphisms and Functional Variation Drug Metab. Dispos., October 1, 2002; 30(10): 1043 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Fisher, K. Yoon, M. L. Vaughn, T. J. Strelevitz, and R. S. Foti Flavin-Containing Monooxygenase Activity in Hepatocytes and Microsomes: In Vitro Characterization and In Vivo Scaling of Benzydamine Clearance Drug Metab. Dispos., October 1, 2002; 30(10): 1087 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Krause, S. C. Glocke, and A. A. Elfarra Sulfoxides as Urinary Metabolites of S-Allyl-L-Cysteine in Rats: Evidence for the Involvement of Flavin-Containing Monooxygenases Drug Metab. Dispos., October 1, 2002; 30(10): 1137 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chiba, X. Xu, J. A. Nishime, S. K. Balani, and J. H. Lin Hepatic Microsomal Metabolism of Montelukast, a Potent Leukotriene D4 Receptor Antagonist, in Humans Drug Metab. Dispos., September 1, 1997; 25(9): 1022 - 1031. [Abstract] [Full Text]
|
|
|
|
|
|
M. Tugnait, E. M. Hawes, G. McKay, A. E. Rettie, R. L. Haining, and K. K. Midha N-Oxygenation of Clozapine by Flavin-Containing Monooxygenase Drug Metab. Dispos., April 1, 1997; 25(4): 524 - 527. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Guo, S. Raeissi, R. B. White, and J. C. Stevens Orphenadrine and Methimazole Inhibit Multiple Cytochrome P450 Enzymes in Human Liver Microsomes Drug Metab. Dispos., March 1, 1997; 25(3): 390 - 393. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
